Background illustration for clinical trials search

Paid Clinical Trials Escondido

Discover 1,807 paid clinical trials in Escondido, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Pharmacogenomic Testing Of the Elderly To Reduce Morbidity

for
Genetics of Drug Metabolism
Location: La Jolla CA, Palm Springs CA, Phoenix AZ, Houston TX,
Sponsor: General Genetics Corporation

Sex: All

Age: 18+

Code: NCT02095769

Recruiting

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

for
End Stage Kidney Disease
Location: La Jolla CA, San Diego CA, La Mesa CA, Chula Vista CA,
Sponsor: CSL Behring

Sex: All

Age: 18+

Code: NCT05485961

Phase 2, Phase 3, Recruiting

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

for
Atrial Fibrillation (AF)
Location: La Jolla CA, Newport Beach CA, Huntington Beach CA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07626411

Phase 3, Recruiting

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

for
Atrial Fibrillation (AF)
Location: La Jolla CA, Huntington Beach CA, Pasadena CA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07430956

Phase 3, Recruiting

StrokeNet Thrombectomy Endovascular Platform

for
Ischemic Stroke
Location: La Jolla CA, San Diego CA, Los Angeles CA, Stanford CA,
Sponsor: Medical University of South Carolina

Sex: All

Age: 18+

Code: NCT06289985

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Strategy for Improving Stroke Treatment Response

for
Ischemic Stroke
Location: La Jolla CA, San Diego CA, Los Angeles CA, Phoenix AZ,
Sponsor: Translational Sciences, Inc.

Sex: All

Age: 18+

Code: NCT05948566

Phase 2, Recruiting

(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis

for
Indolent Systemic Mastocytosis,
Location: La Jolla CA, Los Angeles CA, Palo Alto CA,
Sponsor: Blueprint Medicines Corporation

Sex: All

Age: 18+

Code: NCT04910685

Phase 2, Phase 3, Recruiting

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

for
Clonal Mast Cell Disease, KIT D816V Mutation,
Location: La Jolla CA, San Diego CA, Scottsdale AZ, Tucson AZ,
Sponsor: Blueprint Medicines Corporation

Sex: All

Age: 18+

Code: NCT07143669

Recruiting

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

for
Neutropenia
Location: La Jolla CA, Irvine CA, Los Angeles CA, Phoenix AZ,
Sponsor: X4 Pharmaceuticals

Sex: All

Age: 12+

Code: NCT06056297

Phase 3, Recruiting

Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits

for
Chronic Pain, Prescription Opioid Misuse,
Location: La Jolla CA, Salt Lake City UT, New Brunswick NJ
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT06387290

Phase 3, Recruiting

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

for
Carcinoma, Non-Small-Cell Lung
Location: La Jolla CA, Irvine CA, Orange CA, Corona CA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06667076

Phase 2, Recruiting

A Randomized Controlled Trial of a Nutritional Intervention for Endometriosis

for
Endometriosis
Location: La Jolla CA
Sponsor: University of California, San Diego

Sex: Female

Age: 18 - 45

Code: NCT07090096

Recruiting

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

for
COVID-19 Infection
Location: San Diego CA, La Jolla CA, Granada Hills CA,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07013474

Phase 3, Recruiting

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

for
Multiple Myeloma
Location: San Diego CA, Los Angeles CA, Phoenix AZ, Sacramento CA,
Sponsor: European Myeloma Network B.V.

Sex: All

Age: 18+

Code: NCT05243797

Phase 3, Recruiting

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

for
Crohn's Disease
Location: La Jolla CA, Newport Beach CA, Los Angeles CA,
Sponsor: Takeda

Sex: All

Age: 18 - 70

Code: NCT06045754

Recruiting

Assessment of Urinary Polymerase Chain Reaction (PCR) and Next Generation Sequencing (NGS) Technology in the Evaluation and Management of Females With Chronic Bladder Pain and Cystitis-like Symptoms

for
Interstitial Cystitis, Bladder Pain Syndrome
Location: San Diego CA, Los Angeles CA, Camden NJ
Sponsor: MicroGenDX

Sex: Female

Age: 18 - 70+

Code: NCT05276466

Recruiting

Avoidance-driven Decision Making and Learning in Anorexia Nervosa and Bulimia Nervosa

for
Bulimia Nervosa, Anorexia Nervosa
Location: La Jolla CA
Sponsor: University of California, San Diego

Sex: Female

Age: 18 - 39

Code: NCT06566612

Recruiting

Incentive Processing and Learning in Anorexia Nervosa and Bulimia Nervosa

for
Anorexia Nervosa, Bulimia Nervosa
Location: La Jolla CA
Sponsor: University of California, San Diego

Sex: Female

Age: 18 - 39

Code: NCT05056597

Recruiting

A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

for
HER2-negative Breast Cancer Patients With Brain Metastases
Location: San Diego CA, Duarte CA, Los Angeles CA, Las Vegas NV,
Sponsor: Biostar Pharma, Inc.

Sex: All

Age: 18+

Code: NCT06764940

Phase 2, Recruiting

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

for
Chronic Lymphocytic Leukemia (CLL),
Location: San Diego CA, Duarte CA, Los Angeles CA, Phoenix AZ,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07221500

Phase 2, Recruiting